Wherever you are on your QA journey, we’ve got you covered

Global experts in quality assurance & GxP compliance across pharmaceutical, biotech & medical device manufacturing supply chains.

How Rephine helps to address the key challenges in GMP compliance

  • Navigating Complex Regulations: Understanding and adhering to the intricate global GMP standards.
  • Identifying Compliance Gaps: Spotting and addressing vulnerabilities in your quality management systems.
  • Ensuring Data Integrity: Maintaining accuracy and consistency across all data collection and processing activities.
  • Managing Global Audits: Coordinating and preparing for inspections across multiple international markets.
  • Implementing Effective Solutions: Tailoring corrective actions to meet specific regulatory requirements.

Master GMP Compliance with Rephine: Your Partner of Choice for Seamless Audit Management and Digital Solutions

At Rephine, we offer a comprehensive suite of services designed to navigate the complexities of GMP compliance and ensure pharmaceutical companies meet the highest regulatory standards. Our GMP audits, consultancy services, and regulatory expertise address the most critical challenges, from identifying compliance gaps to managing data integrity and conducting global audits.

This year at CPHI Milan 2024, we’re excited to showcase Rephine Connect, our cutting-edge audit management platform. The platform simplifies and streamlines audit processes, with its latest feature, Connect Wishlist, allowing you to tailor audits to your specific needs. With Rephine Connect, you're empowered to take control of your compliance efforts, ensuring you stay ahead in an ever-evolving regulatory landscape.

Visit us at Stand 2F41 to learn more about how Rephine can help you optimize your compliance strategy and future-proof your business

More Info

Go to article: Home | Cell and gene therapy approvals drive paradigm change in manufacturingGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: Syngene Company InsightGo to article: SyngeneGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: PCI Pharma ServicesGo to article: AlfatestLAB - CPHIGo to article: RHEACELL Company InsightGo to article: In DepthGo to article: Cell and gene therapy approvals drive paradigm change in manufacturingGo to article: After the Lykos debacle, what’s next for psychedelic therapies?Go to article: Compounding pharmacies caught in counterfeit controversyGo to article: How the Covid-19 pandemic will help researchers with the mpox emergencyGo to article: Iterum’s oral sulopenem acceptance hinges on antibiotic stewardship effortsGo to article: Clinical research in the UK must build on industry collaboration, says NIHR directorGo to article: Keytruda and Opdivo: a decade reviewGo to article: Alphial - CPHIGo to article: RephineGo to article: Rephine - CPHIGo to article: Thematic Take: AIGo to article: Thematic Take: contentsGo to article: Foreword: Generative AI as a force of creative destructionGo to article: The road to advanced AI capabilitiesGo to article: AI technology: Market size and growth forecasts Go to article: Timeline: a history of AIGo to article: The impact of AI on the pharma sectorGo to article: Case studies: AI in pharmaGo to article: Latest news: AI in pharmaGo to article: AI boom set to revolutionise healthcare in EuropeGo to article: How NVIDIA grew with the healthcare market instead of pushing into itGo to article: Capturing the genAI boom for drug developmentGo to article: New AI model boosts early osteoporosis diagnosis for ageing populationsGo to article: Impact of AI on metabolic disorder clinical trialsGo to article: Resist temptation to rapidly roll out AI – executives must focus on talent and trainingGo to article: Is AI really helping employees?Go to article: Is your business ready for the rise of AI agents?Go to article: Deal activity related to AI in the pharma industry since 2021Go to article: Sponsored SupplementsGo to article: BEA TechnologiesGo to article: Techniconsult Firenze - CPHIGo to article: Science4TechGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue